Therapeutic drug monitoring and fluoroquinolones for multidrug-resistant tuberculosis

被引：0
|
作者：
Srivastava, Shashikant [1 ,2 ]
Gumbo, Tawanda [3 ]
机构：
[1] Univ Texas Hlth Sci Ctr Tyler, Dept Pulm Immunol, Tyler, TX USA
[2] UT Southwestern Med Ctr, Dept Immunol, Dallas, TX USA
[3] Praedicare Inc, Quantitat Preclin & Clin Sci Dept, Dallas, TX USA
来源：
EUROPEAN RESPIRATORY JOURNAL | 2021年 / 57卷 / 04期
关键词：
PHARMACOKINETICS/PHARMACODYNAMICS; MOXIFLOXACIN; PULMONARY; MODEL;
D O I：
10.1183/13993003.04454-2020
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Fluoroquinolones in multidrug-resistant tuberculosis
    Mohapatra, PR
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2004, 170 (08) : 920 - 921
  • [2] Use of therapeutic drug monitoring for multidrug-resistant tuberculosis patients
    Li, JH
    Burzynski, JN
    Lee, YA
    Berg, D
    Driver, CR
    Ridzon, R
    Musiff, SS
    CHEST, 2004, 126 (06) : 1770 - 1776
  • [3] Moxifloxacin in multidrug-resistant tuberculosis: is there any indication for therapeutic drug monitoring?
    Manika, Katerina
    Chatzika, Kalliopi
    Zarogoulidis, Konstantinos
    Kioumis, Ioannis
    EUROPEAN RESPIRATORY JOURNAL, 2012, 40 (04) : 1051 - 1053
  • [4] Fluoroquinolones for the treatment and prevention of multidrug-resistant tuberculosis
    Sterling, T. R.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2016, 20 (12) : S42 - S47
  • [5] Limited Sampling Strategies for Therapeutic Drug Monitoring of Linezolid in Patients With Multidrug-Resistant Tuberculosis
    Alffenaar, Jan-Willem C.
    Kosterink, Jos G. W.
    van Altena, Richard
    van der Werf, Tjip S.
    Uges, Donald R. A.
    Proost, Johannes H.
    THERAPEUTIC DRUG MONITORING, 2010, 32 (01) : 97 - 101
  • [6] The role of surgery and fluoroquinolones in the treatment of multidrug-resistant tuberculosis
    Toeruen, T.
    Tahaoglu, K.
    Oezmen, I.
    Sevim, T.
    Atac, G.
    Kir, A.
    Guengoer, G.
    Boeluekbasi, Y.
    Maden, E.
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2007, 11 (09) : 979 - 985
  • [7] Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?
    Guglielmetti, Lorenzo
    Le Du, Damien
    Veziris, Nicolas
    Caumes, Eric
    Marigot-Outtandy, Dhiba
    Yazdanpanah, Yazdan
    Robert, Jerome
    Frechet-Jachym, Mathilde
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (02) : 582 - 585
  • [8] Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment?
    Srivastava, Shashikant
    Peloquin, Charles A.
    Sotgiu, Giovanni
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) : 1449 - 1453
  • [9] Therapeutic developments for multidrug-resistant tuberculosis
    Hongfei Duan
    Infection Control, 2024, 1 (04) : 2 - 12
  • [10] Limited sampling strategies for therapeutic drug monitoring of amikacin and kanamycin in patients with multidrug-resistant tuberculosis
    Dijkstra, J. A.
    van Altena, R.
    Akkerman, O. W.
    de Lange, W. C. M.
    Proost, J. H.
    van der Werf, T. S.
    Kosterink, J. G. W.
    Alffenaar, J. W. C.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2015, 46 (03) : 332 - 337
12345